跳至主要内容
临床试验/CTRI/2020/10/028333
CTRI/2020/10/028333已完成3 期

Prospective , multi center ,single blind , randomized controlled study on evaluation of use of , â??AyurCoro3â?? as an adjuvant for the treatment purpose in mild to moderate COVID-19 patients at tertiary care center. - AyurCoro3

Shri Sarveshwar Seva Sahkari Samstha0 个研究点目标入组 174 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
174

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Laboratory confirmed diagnosis of Mild to Moderate COVID-19 patients
  • 2. Agree to consent for the study.
  • 3. All Age groups above 18 Years
  • 4. All genders.

排除标准

  • 1.Patients on ventilator
  • 2.Critically ill patient
  • 3.Dyspnea, respiratory frequency >= 30/min,
  • 4.Blood oxygen saturation (SpO2) <= 90%,
  • 5.PaO2/FiO2 ratio < 300, and/or lung infiltrates > 50% within 24 to 48 hours
  • 6.Patients with altered mental state
  • 7.Patients with multiple organ failure requiring ICU monitoring and treatment.
  • 8.Patients with respiratory failure and requiring mechanical ventilation/
  • 9.Patient who have participated in another investigational study within 3 months prior to enrollment in this study
  • 10.Investigators, study personnel and their first-degree relatives.
  • 11.Pregnant Patients
  • 12.Current or future involvement in the active treatment phase of other interventional research studies (excluding observational/non-interventional studies).
  • 13.Any other clinical reason which may preclude entry in the opinion of the investigator.

研究者

发起方
Shri Sarveshwar Seva Sahkari Samstha

相似试验